Atlas Trials

A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)

Clinical trial NCT05102305 · COMPLETED

Trial details

NCT number
NCT05102305
Sponsor
Boryung Pharmaceutical Co., Ltd
Status
COMPLETED
Study type
OBSERVATIONAL
Chronic Obstructive Pulmonary Disease
Start date
2021-09-09
Primary completion
2022-08-16
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.